ANIK – Anika Therapeutics Inc.

Float Short %

3.2

Margin Of Safety %

-25

Put/Call OI Ratio

0.17

EPS Next Q Diff

0.17

EPS Last/This Y

-0.29

EPS This/Next Y

0.39

Price

9.57

Target Price

Analyst Recom

Performance Q

10.64

Relative Volume

1.28

Beta

0.46

Ticker: ANIK

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	ANIK	9.66	N/A	N/A	0
2025-11-18	ANIK	9.65	0.12	0.00	893
2025-11-19	ANIK	9.51	0.13	0.00	839
2025-11-20	ANIK	9.29	0.13	0.00	839
2025-11-21	ANIK	9.88	0.13	999.99	841
2025-11-24	ANIK	9.88	0.13	999.99	841
2025-11-25	ANIK	9.99	0.17	0.50	605
2025-11-26	ANIK	9.79	0.17	0.00	608
2025-12-01	ANIK	9.77	0.17	0.00	612
2025-12-02	ANIK	9.45	0.17	0.00	612
2025-12-03	ANIK	9.48	0.17	0.00	612
2025-12-04	ANIK	9.49	0.17	999.99	612
2025-12-05	ANIK	9.6	0.17	999.99	612
2025-12-08	ANIK	9.63	0.17	0.00	613
2025-12-09	ANIK	9.52	0.17	0.00	613
2025-12-10	ANIK	9.66	0.17	0.00	613
2025-12-11	ANIK	9.51	0.17	0.00	613
2025-12-12	ANIK	9.57	0.17	0.00	614
2025-12-15	ANIK	9.58	0.17	0.00	614
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-17	ANIK	9.64	166.7	-	-0.13
2025-11-18	ANIK	9.65	166.7	-	-0.13
2025-11-19	ANIK	9.52	166.7	-	-0.13
2025-11-20	ANIK	9.28	166.7	-	-0.13
2025-11-21	ANIK	9.87	166.7	-	-0.13
2025-11-24	ANIK	9.87	166.7	-	-0.13
2025-11-25	ANIK	9.98	166.7	-	-0.13
2025-11-26	ANIK	9.83	166.7	-	-0.13
2025-12-01	ANIK	9.76	166.7	-	-0.13
2025-12-02	ANIK	9.43	166.7	-	-0.13
2025-12-03	ANIK	9.47	166.7	-	-0.13
2025-12-04	ANIK	9.48	166.7	-	-0.13
2025-12-05	ANIK	9.60	166.7	-	-0.13
2025-12-08	ANIK	9.63	166.7	-	-0.13
2025-12-09	ANIK	9.52	166.7	-	-0.13
2025-12-10	ANIK	9.52	166.7	-	-0.13
2025-12-11	ANIK	9.49	166.7	-	-0.13
2025-12-12	ANIK	9.57	166.7	-	-0.13
2025-12-15	ANIK	9.57	166.7	-	-0.13
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-17	ANIK	0.00	5.89	2.24
2025-11-18	ANIK	0.00	5.89	2.24
2025-11-19	ANIK	0.00	5.89	2.24
2025-11-20	ANIK	0.00	5.89	2.24
2025-11-21	ANIK	0.00	5.89	2.24
2025-11-24	ANIK	0.00	-0.54	2.24
2025-11-25	ANIK	0.00	-0.54	2.24
2025-11-26	ANIK	0.00	-0.54	2.39
2025-12-01	ANIK	0.00	-0.56	2.39
2025-12-02	ANIK	0.00	-0.56	2.39
2025-12-03	ANIK	0.00	-0.56	2.39
2025-12-04	ANIK	0.00	-0.56	2.39
2025-12-05	ANIK	0.00	-0.56	2.39
2025-12-08	ANIK	0.00	-0.66	2.39
2025-12-09	ANIK	0.00	-0.66	2.39
2025-12-10	ANIK	0.00	-0.66	3.20
2025-12-11	ANIK	0.00	-0.66	3.20
2025-12-12	ANIK	0.00	-0.66	3.20
2025-12-15	ANIK	0.00	-0.70	3.20
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ANIK" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.17

Avg. EPS Est. Current Quarter

0.02

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.7

Beta

0.46

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

7.15

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

80.2

Max Drawdown 5-Year %

-83.2

Target Price

P/E

Forward P/E

PEG

P/S

1.22

P/B

0.94

P/Free Cash Flow

212.33

EPS

-2.28

Average EPS Est. Cur. Y

-0.13

EPS Next Y. (Est.)

0.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-29.29

Relative Volume

1.28

Return on Equity vs Sector %

-49.5

Return on Equity vs Industry %

-29.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ANIK” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Anika Therapeutics Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 288

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide short-and long-term pain relief. The company's joint preservation and restoration product family comprises orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

stock quote shares ANIK – Anika Therapeutics Inc. Stock Price stock today

news today ANIK – Anika Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ANIK – Anika Therapeutics Inc. yahoo finance google finance

stock history ANIK – Anika Therapeutics Inc. invest stock market

stock prices ANIK premarket after hours

ticker ANIK fair value insiders trading

ANIK – Anika Therapeutics Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ANIK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y